• Biotin-16-UTP: Technical Guide for RNA Labeling Workflows

  2026-05-12

  Biotin-16-UTP is a biotin-labeled uridine triphosphate designed for robust RNA labeling during in vitro transcription. It addresses the need for sensitive, specific RNA detection and purification, particularly in RNA-protein interaction and localization studies. This product is best suited for molecular biology research workflows and should not be used for diagnostic or clinical applications.

• Structural Basis of Primidone (Mysoline) Inhibition of TRPM3

  2026-05-12

  This study reveals the molecular mechanism by which Primidone, a classical antiepileptic, inhibits the TRPM3 cation channel—a target implicated in pain and neurodevelopmental disorders. By solving high-resolution cryo-EM structures of TRPM3 in complex with neurosteroids and inhibitors, the authors provide insights critical for rational drug development and translational research.

• T-5224 (C-Fos/AP-1 inhibitor): Precision Tools for Inflammat

  2026-05-11

  T-5224, a selective C-Fos/AP-1 inhibitor from APExBIO, empowers researchers to dissect and modulate inflammatory and osteoclastogenic pathways with high specificity. Its robust inhibition of MMPs and cytokines translates into reproducible workflows for arthritis and neuroinflammation models, advancing both fundamental discovery and translational research.

• Genistein in Cytoskeleton-Driven Cancer Chemoprevention

  2026-05-11

  Genistein, a selective protein tyrosine kinase inhibitor, uniquely enables researchers to dissect cytoskeleton-dependent signaling and autophagy in cancer models. This article distills the latest mechanotransduction research into actionable workflows and troubleshooting guidance for maximizing Genistein’s impact in advanced cell signaling and chemoprevention assays.

• Thiazovivin (A5506): Protocols for ROCK Inhibition in Stem C

  2026-05-10

  Thiazovivin is a high-purity ROCK inhibitor optimized for enhancing human embryonic stem cell survival and improving the efficiency of induced pluripotent stem cell generation. It is best deployed in research workflows requiring precise ROCK pathway modulation, but is not suitable for clinical, diagnostic, or long-term storage uses.

• U 46619: Applied Protocols for Platelet Aggregation & Vascul

  2026-05-09

  U 46619 (11,9 epoxymethano-prostaglandin H2) is a powerful tool for dissecting platelet and vascular signaling, standing out for its reproducibility and precise control over TP receptor activation. This article delivers actionable workflows, troubleshooting guidance, and evidence-based parameters to maximize experimental rigor in cardiovascular and renal research.

• Bufalin: Cardiotoic Steroid Transforming Cancer Cell Researc

  2026-05-08

  Bufalin, a potent cardiotonic steroid from APExBIO, enables precise apoptosis induction and molecular target degradation in triple-negative breast cancer and hepatocellular carcinoma research. This guide delivers actionable workflows, advanced troubleshooting, and protocol enhancements to maximize reproducibility and scientific insight at the bench.

• Optimizing Immunoblotting with ECL Chemiluminescent Substrat

  2026-05-08

  This article addresses key laboratory challenges in immunoblotting detection of low-abundance proteins using the ECL Chemiluminescent Substrate Detection Kit (Hypersensitive), SKU K1231. Grounded in experimental evidence and practical workflow analysis, it guides researchers on maximizing sensitivity, reproducibility, and cost-efficiency in HRP-mediated chemiluminescence assays.

• Redefining In Vitro Drug Response Metrics in Cancer Research

  2026-05-07

  This dissertation by Hannah R. Schwartz introduces a nuanced approach to evaluating anti-cancer drug responses in vitro by distinguishing between relative viability and fractional viability metrics. The study’s findings have significant implications for interpreting drug mechanism and optimizing preclinical cancer research protocols.

• Dissecting In Vitro Drug Response Metrics in Cancer Research

  2026-05-07

  Schwartz (2022) critically examines the differences between relative viability and fractional viability in in vitro cancer drug studies, revealing that these metrics capture distinct aspects of drug response. The work highlights the importance of separating proliferative arrest from cell death in evaluating anticancer agents, with practical implications for interpreting assays and designing robust preclinical workflows.

• Balsalazide Disodium: Efficacy and Mechanisms in Ulcerative

  2026-05-06

  This article examines the foundational study by Wiggins & Rajapakse on balsalazide disodium, a prodrug of 5-aminosalicylic acid (5-ASA), in the management of ulcerative colitis. The review highlights its innovative colonic activation mechanism, clinical efficacy for remission induction, and comparative advantages over other 5-ASA preparations, offering practical insights for inflammation research and immunology assay design.

• KPT330 Enhances CRISPR-Cas9 Precision via mRNA Export Modula

  2026-05-06

  This article examines how KPT330, a selective inhibitor of nuclear export, improves the specificity of CRISPR-Cas9 genome and base editing by indirectly regulating Cas9 mRNA nuclear export. The findings suggest a novel strategy for minimizing off-target effects in mammalian genome editing workflows.

• Multimodal MSC-EV Therapy Targets Pancreatic Fibrosis via MF

  2026-05-05

  This study demonstrates that umbilical cord-derived mesenchymal stem cells (UCMSCs) and their extracellular vesicles (EVs) alleviate pancreatic fibrosis in chronic pancreatitis by modulating the MFGE8-dependent ANXA1-SMAD2/3 signaling pathway. The research further introduces a novel rhMFGE8 nanoparticle delivery system, highlighting new directions for antifibrotic therapy and regenerative medicine applications.

• Caffeine (1,3,7-trimethylpurine-2,6-dione): Protocols & Pitf

  2026-05-05

  Caffeine (1,3,7-trimethylpurine-2,6-dione) is a versatile research tool for dissecting cancer cell line inhibition and energy metabolism pathways. This guide deciphers bench-ready workflows, troubleshooting tips, and actionable insights for maximizing reproducibility with APExBIO's high-quality reagent.

• Temozolomide: Small-Molecule Alkylating Agent for Glioma Res

  2026-05-04

  Temozolomide’s precise DNA methylation makes it indispensable for dissecting DNA repair mechanisms and modeling chemotherapy resistance in glioma research. With robust solubility in DMSO and validated synergy in ATRX-deficient systems, it empowers advanced workflows and translational insights.

14941 records 1/997 page Next 12345 下5页 Last page